SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    D. Schmid, H.W. Kuo, E. Simons, E.E. Kanitz, J. Wenisch, F. Allerberger, C. Wenisch, All-cause mortality in hospitalized patients with infectious diarrhea: Clostridium difficile versus other enteric pathogens in Austria from 2008 to 2010, Journal of Infection and Public Health, 2014, 7, 2, 133

    CrossRef

  2. 2
    Craig A. Vargo, Karri A. Bauer, Julie E. Mangino, Jessica E.W. Johnston, Debra A. Goff, An Antimicrobial Stewardship Program's Real-World Experience with Fidaxomicin for Treatment of Clostridium difficile Infection: A Case Series, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014, 34, 9
  3. 3
    Dominika Lachowicz, Hanna Pituch, Piotr Obuch-Woszczatyński, Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012, Anaerobe, 2014,

    CrossRef

  4. 4
    D. Baldoni, M. Gutierrez, W. Timmer, J. Dingemanse, Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral doses, Journal of Antimicrobial Chemotherapy, 2014, 69, 3, 706

    CrossRef

  5. 5
    Jyotika B. Varshney, Katherine J. Very, Jen L. Williams, John P. Hegarty, David B. Stewart, Jeanne Lumadue, Kumar Venkitanarayanan, Bhushan M. Jayarao, Characterization ofClostridium difficileIsolates from Human Fecal Samples and Retail Meat from Pennsylvania, Foodborne Pathogens and Disease, 2014, 11, 10, 822

    CrossRef

  6. 6
    F. F. Zhou, S. Wu, J. D. Klena, H. H. Huang, Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China, European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33, 10, 1773

    CrossRef

  7. 7
    Robin L. P. Jump, Curtis J. Donskey, Clostridium difficile in the Long-Term Care Facility: Prevention and Management, Current Geriatrics Reports, 2014,

    CrossRef

  8. 8
    Carolyn D. Alonso, Mini Kamboj, Clostridium difficile Infection (CDI) in Solid Organ and Hematopoietic Stem Cell Transplant Recipients, Current Infectious Disease Reports, 2014, 16, 8

    CrossRef

  9. 9
    Maria J.G.T. Vehreschild, David Weitershagen, Lena M. Biehl, Daniela Tacke, Dirk Waldschmidt, Ulrich Töx, Hilmar Wisplinghoff, Michael v. Bergwelt-Baildon, Oliver A. Cornely, Joerg J. Vehreschild, Clostridium Difficile Infection in Patients with Acute Myelogenous Leukemia and in Patients Undergoing Allogeneic Stem Cell Transplantation: Epidemiology and Risk Factor Analysis, Biology of Blood and Marrow Transplantation, 2014, 20, 6, 823

    CrossRef

  10. 10
    Alejandro Callejas-Díaz, Juan C. Gea-Banacloche, Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation, Current Hematologic Malignancy Reports, 2014, 9, 1, 85

    CrossRef

  11. 11
    Peter M. Markus, Clostridium-difficile-assoziierte Kolitis, CME, 2014, 11, 6, 48

    CrossRef

  12. 12
    Beatriz Castro, Miriam Hernández-Porto, Vanessa Felipe-Díaz, María Lecuona, Colitis severa por Clostridium difficile ribotipo 027 adquirido en la comunidad, Enfermedades Infecciosas y Microbiología Clínica, 2014, 32, 7, 471

    CrossRef

  13. 13
    B. Lakshminarayanan, C. Stanton, P. W. O’Toole, R. Paul Ross, Compositional dynamics of the human intestinal microbiota with aging: Implications for health, The journal of nutrition, health & aging, 2014,

    CrossRef

  14. 14
    B. Lakshminarayanan, C. Stanton, P. W. O’Toole, R. Paul Ross, Compositional dynamics of the human intestinal microbiota with aging: Implications for health, The journal of nutrition, health & aging, 2014, 18, 9, 773

    CrossRef

  15. 15
    D. Nathwani, O. A. Cornely, A. K. Van Engen, O. Odufowora-Sita, P. Retsa, I. A. O. Odeyemi, Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection, Journal of Antimicrobial Chemotherapy, 2014, 69, 11, 2901

    CrossRef

  16. 16
    J. Stahlmann, M. Schönberg, M. Herrmann, L. Müller, Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples, Clinical Microbiology and Infection, 2014, 20, 9
  17. 17
    S. K. Lim, R. L. Stuart, K. E. Mackin, G. P. Carter, D. Kotsanas, M. J. Francis, M. Easton, K. Dimovski, B. Elliott, T. V. Riley, G. Hogg, E. Paul, T. M. Korman, T. Seemann, T. P. Stinear, D. Lyras, G. A. Jenkin, Emergence of a Ribotype 244 Strain of Clostridium difficile Associated With Severe Disease and Related to the Epidemic Ribotype 027 Strain, Clinical Infectious Diseases, 2014, 58, 12, 1723

    CrossRef

  18. 18
    F. Alvarez-Lerma, M. Palomar, A. Villasboa, J. Amador, J. Almirall, M.P. Posada, M. Catalan, C. Pascual, Epidemiological study of Clostridium difficile infection in critical patients admitted to the Intensive Care Unit, Medicina Intensiva (English Edition), 2014, 38, 9, 558

    CrossRef

  19. 19
    Gustavo Lopardo, Rayo Morfin-Otero, Iliana Isabel Moran-Vazquez, Fernando Noriega, Betzana Zambrano, Christine Luxemburger, Ginamarie Foglia, Enrique Eduardo Rivas, Epidemiology of Clostridium difficile: a hospital-based descriptive study in Argentina and Mexico, The Brazilian Journal of Infectious Diseases, 2014,

    CrossRef

  20. 20
    F. Alvarez-Lerma, M. Palomar, A. Villasboa, J. Amador, J. Almirall, M.P. Posada, M. Catalan, C. Pascual, Estudio epidemiológico de infección por Clostridium difficile en pacientes críticos ingresados en una Unidad de Cuidados Intensivos, Medicina Intensiva, 2014, 38, 9, 558

    CrossRef

  21. You have free access to this content21
    S. B. Debast, M. P. Bauer, E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clinical Microbiology and Infection, 2014, 20,
  22. 22
    Heejung Kim, Wan Hee Kim, Myungsook Kim, Seok Hoon Jeong, Kyungwon Lee, Evaluation of a Rapid Membrane Enzyme Immunoassay for the Simultaneous Detection of Glutamate Dehydrogenase and Toxin for the Diagnosis ofClostridium difficileInfection, Annals of Laboratory Medicine, 2014, 34, 3, 235

    CrossRef

  23. 23
    Mercedes Marín, Adoración Martín, Adela Alcolea, Cristina Iglesias, Luis Alcalá, Teresa Peláez, Mar Sánchez-Somolinos, Emilio Bouza, First case of autochthonous Clostridium difficile PCR ribotype 027 detected in Spain, Enfermedades Infecciosas y Microbiología Clínica, 2014, 32, 6, 355

    CrossRef

  24. 24
    Anita Novak, Patrizia Spigaglia, Fabrizio Barbanti, Ivana Goic-Barisic, Marija Tonkic, First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital, Anaerobe, 2014, 30, 18

    CrossRef

  25. 25
    Mamun-Ur Rashid, Axel Dalhoff, Andrej Weintraub, Carl Erik Nord, In vitro activity of MCB3681 against Clostridium difficile strains, Anaerobe, 2014, 28, 216

    CrossRef

  26. 26
    Mónica Oleastro, Marta Coelho, Marília Gião, Salomé Coutinho, Sandra Mota, Andrea Santos, João Rodrigues, Domitília Faria, Outbreak of Clostridium difficile PCR ribotype 027 - the recent experience of a regional hospital, BMC Infectious Diseases, 2014, 14, 1, 209

    CrossRef

  27. 27
    Gerald A Denys, Portrait ToxigenicClostridium difficileassay, an isothermal amplification assay detects toxigenicC. difficilein clinical stool specimens, Expert Review of Molecular Diagnostics, 2014, 14, 1, 17

    CrossRef

  28. 28
    M. P. M. Hensgens, O. M. Dekkers, A. Goorhuis, S. LeCessie, E. J. Kuijper, Predicting a complicated course of Clostridium difficile infection at the bedside, Clinical Microbiology and Infection, 2014, 20, 5
  29. 29
    Young Kyung Yoon, Min Ja Kim, Jang Wook Sohn, Hye Suk Kim, Yoon Ji Choi, Jung Sun Kim, Seung Tae Kim, Kyong Hwa Park, Seok Jin Kim, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Yong Park, Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy, Supportive Care in Cancer, 2014, 22, 8, 2039

    CrossRef

  30. 30
    Haihui Huang, Shi Wu, Renjie Chen, Shaohua Xu, Hong Fang, Andrej Weintraub, Carl Erik Nord, Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China, Anaerobe, 2014, 30, 65

    CrossRef

  31. 31
    Peter Starzengruber, Luigi Segagni Lusignani, Thomas Wrba, Dieter Mitteregger, Alexander Indra, Wolfgang Graninger, Elisabeth Presterl, Magda Diab-Elschahawi, Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria, Wiener klinische Wochenschrift, 2014, 126, 13-14, 427

    CrossRef

  32. 32
    C. Bermejo, E. Maseda, P. Salgado, G. Gabilondo, F. Gilsanz, Shock séptico debido a la infección por Clostridium difficile adquirida en la comunidad. Estudio de un caso y revisión de la literatura, Revista Española de Anestesiología y Reanimación, 2014, 61, 4, 219

    CrossRef

  33. 33
    Hitoshi Honda, Erik R. Dubberke, The changing epidemiology of Clostridium difficile infection, Current Opinion in Gastroenterology, 2014, 30, 1, 54

    CrossRef

  34. 34
    A. Le Monnier, J.-R. Zahar, F. Barbut, Update on Clostridium difficile infections, Médecine et Maladies Infectieuses, 2014, 44, 8, 354

    CrossRef

  35. 35
    Rosanna Leuzzi, Roberto Adamo, Maria Scarselli, Vaccines againstClostridium difficile, Human Vaccines & Immunotherapeutics, 2014, 10, 6, 1466

    CrossRef

  36. 36
    S. Johnson, T. J. Louie, D. N. Gerding, O. A. Cornely, S. Chasan-Taber, D. Fitts, S. P. Gelone, C. Broom, D. M. Davidson, Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials, Clinical Infectious Diseases, 2014, 59, 3, 345

    CrossRef

  37. 37
    Valentin Brodszky, László Gulácsi, Endre Ludwig, Gyula Prinz, János Banai, Péter Reményi, Bálint Strbák, Adrienne Kertész, Irén Kopcsóné Németh, Edit Zsoldiné Urbán, Petra Baji, Márta Péntek, A <i>Clostridium difficile</i>-fertőzések antibiotikum-terápiája. A tudományos bizonyítékok szisztematikus áttekintése és metaanalízise, Orvosi Hetilap, 2013, 154, 23, 890

    CrossRef

  38. 38
    S. B. Debast, M. P. Bauer, I. M. J. G. Sanders, M. H. Wilcox, E. J. Kuijper, Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications, Journal of Antimicrobial Chemotherapy, 2013, 68, 6, 1305

    CrossRef

  39. 39
    Laith Yakob, Thomas V Riley, David L Paterson, Archie CA Clements, Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model, BMC Infectious Diseases, 2013, 13, 1, 376

    CrossRef

  40. 40
    J.D. Stanley, J.G. Bartlett, B.W. Dart, J.H. Ashcraft, Clostridium difficile infection, Current Problems in Surgery, 2013, 50, 7, 302

    CrossRef

  41. 41
    Carolyn D. Alonso, Kieren A. Marr, Clostridium difficile infection among hematopoietic stem cell transplant recipients, Current Opinion in Infectious Diseases, 2013, 1

    CrossRef

  42. 42
    Paul J. Collini, Ed Kuijper, David H. Dockrell, Clostridium Difficile Infection in Patients with HIV/AIDS, Current HIV/AIDS Reports, 2013, 10, 3, 273

    CrossRef

  43. 43
    A.M. Jones, E.J. Kuijper, M.H. Wilcox, Clostridium difficile: A European perspective, Journal of Infection, 2013, 66, 2, 115

    CrossRef

  44. 44
    Robin LP Jump, Clostridium difficileinfection in older adults, Aging Health, 2013, 9, 4, 403

    CrossRef

  45. 45
    Geom Seog Seo, Clostridium difficileInfection: What's New?, Intestinal Research, 2013, 11, 1, 1

    CrossRef

  46. 46
    S.N. Bass, S.R. Bauer, E.A. Neuner, S.W. Lam, Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection, Journal of Hospital Infection, 2013, 85, 1, 22

    CrossRef

  47. 47
    D.N. Shah, N.S. Bhatt, J.K. Welch, H.L. Koo, K.W. Garey, Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection, Journal of Hospital Infection, 2013, 83, 4, 294

    CrossRef

  48. 48
    Mark A Miller, Thomas Louie, Kathleen Mullane, Karl Weiss, Arnold Lentnek, Yoav Golan, Yin Kean, Pam Sears, Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy, BMC Infectious Diseases, 2013, 13, 1, 148

    CrossRef

  49. 49
    M. J. G. T. Vehreschild, J. J. Vehreschild, K. Hubel, M. Hentrich, M. Schmidt-Hieber, M. Christopeit, G. Maschmeyer, E. Schalk, O. A. Cornely, S. Neumann, Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Annals of Oncology, 2013, 24, 5, 1189

    CrossRef

  50. 50
    Catherine Eckert, Gabrielle Jones, Frédéric Barbut, Diagnosis ofClostridium difficileinfection: the molecular approach, Future Microbiology, 2013, 8, 12, 1587

    CrossRef

  51. 51
    Richard Strauß, M. F. Neurath, Die Infektionen bleiben eine große Herausforderung, MMW - Fortschritte der Medizin, 2013, 155, 7, 57

    CrossRef

  52. 52
    Diana Monge, Isabel Millán, Alba González-Escalada, Ángel Asensio, Efecto de la infección por Clostridium difficile sobre la estancia hospitalaria. Estudio de cohortes, Enfermedades Infecciosas y Microbiología Clínica, 2013, 31, 10, 660

    CrossRef

  53. 53
    Thomas J. Louie, Mark A. Miller, Derrick W. Crook, Arnold Lentnek, Louis Bernard, Kevin P. High, Youe-Kong Shue, Sherwood L. Gorbach, Effect of Age on Treatment Outcomes in Clostridium difficile Infection, Journal of the American Geriatrics Society, 2013, 61, 2
  54. 54
    Simon W. Lam, Stephanie N. Bass, Elizabeth A. Neuner, Seth R. Bauer, Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection, International Journal of Antimicrobial Agents, 2013, 42, 6, 553

    CrossRef

  55. 55
    Zain Kassam, Christine H Lee, Yuhong Yuan, Richard H Hunt, Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis, The American Journal of Gastroenterology, 2013, 108, 4, 500

    CrossRef

  56. 56
    Melinda M Soriano, Siyun Liao, Larry H Danziger, Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment ofClostridium difficileinfections, Expert Review of Anti-infective Therapy, 2013, 11, 8, 767

    CrossRef

  57. 57
    Christina M Surawicz, Lawrence J Brandt, David G Binion, Ashwin N Ananthakrishnan, Scott R Curry, Peter H Gilligan, Lynne V McFarland, Mark Mellow, Brian S Zuckerbraun, Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections, The American Journal of Gastroenterology, 2013, 108, 4, 478

    CrossRef

  58. 58
    Mamun-Ur Rashid, Helena Martinez Lozano, Andrej Weintraub, Carl Erik Nord, In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden, Anaerobe, 2013, 20, 32

    CrossRef

  59. 59
    Dolors Rodríguez-Pardo, Beatriz Mirelis, Ferran Navarro, Infecciones producidas por Clostridium difficile, Enfermedades Infecciosas y Microbiología Clínica, 2013, 31, 4, 254

    CrossRef

  60. 60
    Hans Jürgen Heppner, Sieber Cornel, Walger Peter, Bahrmann Philipp, Singler Katrin, Infections in the Elderly, Critical Care Clinics, 2013, 29, 3, 757

    CrossRef

  61. 61
    S. M. Brecher, S. M. Novak-Weekley, E. Nagy, Laboratory Diagnosis of Clostridium difficile Infections: There Is Light at the End of the Colon, Clinical Infectious Diseases, 2013, 57, 8, 1175

    CrossRef

  62. 62
    C. Lübbert, S. Weis, Medikamentöse Therapie der infektiösen Diarrhö, Der Internist, 2013, 54, 11, 1383

    CrossRef

  63. 63
    K. Solomon, A. J. Martin, C. O'Donoghue, X. Chen, L. Fenelon, S. Fanning, C. P. Kelly, L. Kyne, Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses, Journal of Medical Microbiology, 2013, 62, Pt_9, 1453

    CrossRef

  64. 64
    Dolors Rodríguez-Pardo, Beatriz Mirelis, Ferran Navarro, Réplica a «Infecciones producidas por Clostridium difficile. Observaciones», Enfermedades Infecciosas y Microbiología Clínica, 2013, 31, 8, 558

    CrossRef

  65. You have free access to this content65
    E. Mattila, P. Arkkila, P. S. Mattila, E. Tarkka, P. Tissari, V.-J. Anttila, Rifaximin in the treatment of recurrent Clostridium difficile infection, Alimentary Pharmacology & Therapeutics, 2013, 37, 1
  66. 66
    B. Salzberger, F. Hanses, G. Birkenfeld, J. Langgartner, Schwere Infektionen, Der Internist, 2013, 54, 8, 925

    CrossRef

  67. 67
    D. Bossé, C. Lemire, J. Ruel, A. M. Cantin, F. Ménard, L. Valiquette, Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection, Infection, 2013, 41, 2, 579

    CrossRef

  68. 68
    Reena Khanna, Nilesh Chande, Richard L. Nelson, Treatment of an Initial Infection with Clostridium difficile in Patients with Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 2013, 19, 10, 2223

    CrossRef

  69. 69
    Jessica Martin, Mark Wilcox, Clostridium difficile: New Challenges for an Old Foe, 2013,

    CrossRef

  70. 70
    Domonka Fodor, Kiddy Levente Ume, Mónika Matkó, Enikő Nacsa, Edit Urbán, Edit Hajdú, <i>Clostridium difficile</i> okozta akut gastroenteritis fertőzőosztályon, Orvosi Hetilap, 2012, 153, 50, 1992

    CrossRef

  71. 71
    J. M. Wenisch, D. Schmid, G. Tucek, H.-W. Kuo, F. Allerberger, V. Michl, P. Tesik, H. Laferl, C. Wenisch, A prospective cohort study on hospital mortality due to Clostridium difficile infection, Infection, 2012, 40, 5, 479

    CrossRef

  72. You have free access to this content72
    F. Fitzpatrick, F. Barbut, Breaking the cycle of recurrent Clostridium difficile infections, Clinical Microbiology and Infection, 2012, 18,
  73. You have free access to this content73
    C. P. Kelly, Can we identify patients at high risk of recurrent Clostridium difficile infection?, Clinical Microbiology and Infection, 2012, 18,
  74. 74
    P.N. Wiegand, D. Nathwani, M.H. Wilcox, J. Stephens, A. Shelbaya, S. Haider, Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection, Journal of Hospital Infection, 2012, 81, 1, 1

    CrossRef

  75. 75
    L. M. Søes, I. Brock, S. Persson, J. Simonsen, K. E. Pribil Olsen, M. Kemp, Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients, European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31, 2, 185

    CrossRef

  76. 76
    Stefano Di Bella, Maria Grazia Paglia, Emma Johnson, Nicola Petrosillo, Clostridium difficile 027 infection in Central Italy, BMC Infectious Diseases, 2012, 12, 1, 370

    CrossRef

  77. 77
    Andrea Lo Vecchio, George M. Zacur, Clostridium difficile infection, Current Opinion in Gastroenterology, 2012, 28, 1, 1

    CrossRef

  78. 78
    Lise Willems, Raphaël Porcher, Matthieu Lafaurie, Isabelle Casin, Marie Robin, Aliénor Xhaard, Anna Lisa Andreoli, Paula Rodriguez-Otero, Nathalie Dhedin, Gérard Socié, Patricia Ribaud, Régis Peffault de Latour, Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome, Biology of Blood and Marrow Transplantation, 2012, 18, 8, 1295

    CrossRef

  79. 79
    Paul J. Collini, Martijn Bauer, Ed Kuijper, David H. Dockrell, Clostridium difficile infection in HIV-seropositive individuals and transplant recipients, Journal of Infection, 2012, 64, 2, 131

    CrossRef

  80. You have free access to this content80
    E. Bouza, Consequences of Clostridium difficile infection: understanding the healthcare burden, Clinical Microbiology and Infection, 2012, 18,
  81. You have free access to this content81
    O. A. Cornely, Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?, Clinical Microbiology and Infection, 2012, 18,
  82. 82
    Ciarán P. Kelly, Current strategies for management of initial Clostridium difficile infection, Journal of Hospital Medicine, 2012, 7, S3
  83. 83
    Elisabeth Krones, Christoph Högenauer, Diarrhea in the Immunocompromised Patient, Gastroenterology Clinics of North America, 2012, 41, 3, 677

    CrossRef

  84. 84
    Matteo Bassetti, Giovanni Villa, Davide Pecori, Alessandra Arzese, Mark Wilcox, Epidemiology, diagnosis and treatment ofClostridium difficileinfection, Expert Review of Anti-infective Therapy, 2012, 10, 12, 1405

    CrossRef

  85. 85
    P. Sears, D. W. Crook, T. J. Louie, M. A. Miller, K. Weiss, Fidaxomicin Attains High Fecal Concentrations With Minimal Plasma Concentrations Following Oral Administration in Patients With Clostridium difficile Infection, Clinical Infectious Diseases, 2012, 55, suppl 2, S116

    CrossRef

  86. 86
    Oliver A Cornely, Derrick W Crook, Roberto Esposito, André Poirier, Michael S Somero, Karl Weiss, Pamela Sears, Sherwood Gorbach, Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial, The Lancet Infectious Diseases, 2012, 12, 4, 281

    CrossRef

  87. 87
    N. Bourgeois-Nicolaos, C. Guillet-Caruba, Glycopeptides, EMC - Maladies infectieuses, 2012, 9, 2, 1

    CrossRef

  88. 88
    J. M. Wenisch, D. Schmid, H.-W. Kuo, E. Simons, F. Allerberger, V. Michl, P. Tesik, G. Tucek, C. Wenisch, Hospital-acquired Clostridium difficile infection: determinants for severe disease, European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31, 8, 1923

    CrossRef

  89. 89
    Fabien Rebeaud, Martin F Bachmann, Immunization strategies forClostridium difficileinfections, Expert Review of Vaccines, 2012, 11, 4, 469

    CrossRef

  90. 90
    F. Barbut, A. Le Monnier, C. Eckert, Infections à Clostridium difficile : aspects cliniques épidémiologiques et thérapeutiques, Réanimation, 2012, 21, S2, 373

    CrossRef

  91. You have free access to this content91
    M. H. Wilcox, Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection, Clinical Microbiology and Infection, 2012, 18,
  92. 92
    Mark H Wilcox, Progress with a difficult infection, The Lancet Infectious Diseases, 2012, 12, 4, 256

    CrossRef

  93. 93
    M. M. Nerandzic, K. Mullane, M. A. Miller, F. Babakhani, C. J. Donskey, Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection, Clinical Infectious Diseases, 2012, 55, suppl 2, S121

    CrossRef

  94. 94
    M. P. Bauer, M. P. M. Hensgens, M. A. Miller, D. N. Gerding, M. H. Wilcox, A. P. Dale, W. N. Fawley, E. J. Kuijper, S. L. Gorbach, Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis, Clinical Infectious Diseases, 2012, 55, suppl 2, S149

    CrossRef

  95. You have free access to this content95
    B. Guo, C. Harstall, T. Louie, S. Veldhuyzen van Zanten, L. A. Dieleman, Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease, Alimentary Pharmacology & Therapeutics, 2012, 35, 8
  96. 96
    S. M. Bartsch, S. R. Curry, L. H. Harrison, B. Y. Lee, The potential economic value of screening hospital admissions for Clostridium difficile, European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31, 11, 3163

    CrossRef

  97. 97
    M. P. M. Hensgens, A. Goorhuis, O. M. Dekkers, E. J. Kuijper, Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics, Journal of Antimicrobial Chemotherapy, 2012, 67, 3, 742

    CrossRef

  98. 98
    Konstantinos Z. Vardakas, Konstantinos A. Polyzos, Konstantina Patouni, Petros I. Rafailidis, George Samonis, Matthew E. Falagas, Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence, International Journal of Antimicrobial Agents, 2012, 40, 1, 1

    CrossRef

  99. 99
    O. A. Cornely, M. A. Miller, T. J. Louie, D. W. Crook, S. L. Gorbach, Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin, Clinical Infectious Diseases, 2012, 55, suppl 2, S154

    CrossRef

  100. 100
    J. G. Bartlett, A Call to Arms: The Imperative for Antimicrobial Stewardship, Clinical Infectious Diseases, 2011, 53, suppl 1, S4

    CrossRef

  101. 101
    Martijn P Bauer, Daan W Notermans, Birgit HB van Benthem, Jon S Brazier, Mark H Wilcox, Maja Rupnik, Dominique L Monnet, Jaap T van Dissel, Ed J Kuijper, Clostridium difficile infection in Europe: a hospital-based survey, The Lancet, 2011, 377, 9759, 63

    CrossRef

  102. 102
    C. Eckert, V. Lalande, F. Barbut, Diagnostic des infections à Clostridium difficile, Journal des Anti-infectieux, 2011, 13, 2, 67

    CrossRef

  103. 103
    Sean T. Duggan, Fidaxomicin, Drugs, 2011, 71, 18, 2445

    CrossRef

  104. 104
    Marika Mikelsaar, Human microbial ecology: Lactobacilli, probiotics, selective decontamination, Anaerobe, 2011, 17, 6, 463

    CrossRef

  105. 105
    Mark H. Wilcox, Predicting the Severity of Clostridium Difficile Infection, Infectious Diseases in Clinical Practice, 2011, 19, 5, 305

    CrossRef

  106. 106
    Xi Na, Ciaran Kelly, Probiotics in Clostridium difficile Infection, Journal of Clinical Gastroenterology, 2011, 45, S154

    CrossRef

  107. 107
    Claire M.F. van Nispen tot Pannerden, Annelies Verbon, Ernst J. Kuipers, Recurrent Clostridium difficile Infection, Drugs, 2011, 71, 7, 853

    CrossRef

  108. 108
    David A. Kennedy, Nagarajan Vembu, Frank R. Fronczek, Marc Devocelle, Synthesis of Mutual Azo Prodrugs of Anti-inflammatory Agents and Peptides Facilitated by α-Aminoisobutyric Acid, The Journal of Organic Chemistry, 2011, 76, 23, 9641

    CrossRef

  109. 109
    F. Barbut, J.-L. Meynard, C. Eckert, Traitement des infections digestives à Clostridium difficile : anciennes et nouvelles approches, Journal des Anti-infectieux, 2011, 13, 2, 74

    CrossRef

  110. 110
    Caoilfhionn OʼDonoghue, Lorraine Kyne, Update on Clostridium difficile infection, Current Opinion in Gastroenterology, 2011, 27, 1, 38

    CrossRef

  111. 111
    Caitlin R. Musgrave, P. Brandon Bookstaver, S. Scott Sutton, April D. Miller, Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection, International Journal of Infectious Diseases, 2011, 15, 7, e438

    CrossRef

  112. 112
    Teena Chopra, George J Alangaden, Pranatharthi Chandrasekar, Clostridium difficileinfection in cancer patients and hematopoietic stem cell transplant recipients, Expert Review of Anti-infective Therapy, 2010, 8, 10, 1113

    CrossRef

  113. 113
    Dhara Shah, Minh-Duc Dang, Rodrigo Hasbun, Hoonmo L Koo, Zhi-Dong Jiang, Herbert L DuPont, Kevin W Garey, Clostridium difficileinfection: update on emerging antibiotic treatment options and antibiotic resistance, Expert Review of Anti-infective Therapy, 2010, 8, 5, 555

    CrossRef

  114. 114
    B. Salzberger, Clostridium-difficile-Kolitis, Intensivmedizin und Notfallmedizin, 2010, 47, 4, 272

    CrossRef

  115. 115
    Ian R Poxton, Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment ofClostridium difficileinfections, Future Microbiology, 2010, 5, 4, 539

    CrossRef

  116. 116
    Catherine Eckert, Frédéric Barbut, Les diarrhées post-antibiotiques, Revue Francophone des Laboratoires, 2010, 2010, 426, 93

    CrossRef

  117. You have free access to this content117
    Richard L Nelson, Philippa Kelsey, Hayley Leeman, Naomi Meardon, Haymesh Patel, Kim Paul, Richard Rees, Ben Taylor, Elizabeth Wood, Rexanna Malakun, Antibiotic treatment for Clostridium difficile-associated diarrhea in adults, The Cochrane Library,